Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).


For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.


We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.


In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.


We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.


We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.


The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.


Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.


Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.


If you want more information or have any questions or comments relating to our privacy policy please email [email protected] in the first instance.

 Information  X 
Enter a valid email address

Cherwell Capital PLC (CHEP)

  Print      Mail a friend

Wednesday 16 December, 2009

Cherwell Capital PLC

Interim Results

CHERWELL capital Plc


For the six months ending 30 September 2009.

I have pleasure in presenting to our shareholders our review of Cherwell
Capital Plc's Accounts covering the six month period to 30 September 2009.

Cherwell's net asset value at 30 September 2009 amounted to £547,164 compared
to £461,065 for the period ending 31 March 2009. The carrying value of our
investments and cash in hand is now £469,317 against £433,968 previously and a
provision, possibly over conservative, of £35,000 has been made for tax.

This substantial improvement in liquidity is due to the acquisition of
BIOANALAB by Millipore of the US. Cherwell received a return of four times its
original investment.

Our remaining holding of note is SCANCELL HOLDINGS plc which is developing some
unique approaches to the treatment of cancer by developing vaccines derived
from therapeutic monoclonal antibodies which, in turn, have the ability to
directly kill cells in clinically relevant tumours. Scancell is about to start
a Phase I clinical trial on its lead compound for treatment of malignant
melanoma and the company's shares are listed on PLUSMarkets. The value
attributable to both MINDWEAVERS and ENKEPHALA have been written down as it is
the view of the directors that both are likely to face problems in raising
further finance in very difficult markets

Nevertheless, we have had a significantly above average success rate in the six
investments made since 2002, a rate which would be enhanced further if
SCANCELL'S vaccines are successful in overcoming the major hurdle of each of
the three phases of clinical trials - the most difficult part of achieving
commercial success.

The Company has made a few small - very small - investments in traded stocks in
resource companies, while it considers later stage investment opportunities
which could yield a much faster return than that of BioAnaLab.

The Ordinary and Special Resolutions proposed at the AGM and EGM on 25th
September 2009 were all passed unanimously. The Special Resolutions, together
with those from previous years, have been consolidated into the revised
Memorandum & Articles of Association filed at Companies House.

Professor Bruce Savage,


CHERWELL CAPITAL PLC Interim unaudited figures for 6 months to 30.09.09


                 6 Months to 30.09.09      12 Months to 31.03.09      6 Months to 30.09.08

                Revenue  Capital Total    Revenue  Capital Total    Revenue Capital  Total   
                  GBP      GBP     GBP      GBP      GBP     GBP      GBP     GBP      GBP   
Gains/(losses)  -        155,335 155,335  -        112,904 112,904  -       (58,783) (58,783)
on investments                                                                               
Income          -        -       -        -        -       -        -       -        -       
Other expenses  (34,236) -       (34,409) (20,526) (2)     (20,528) (7,581) -        ( 7,581)
Return on       (34,236) 155,335 120,926  (20,526) 112,902 92,376   (7,581) (58,783) (66,364)
before tax                                                                                   
Tax on ordinary (35,000) -       (35,000) -        -       -        -       -        -       
activities      -                                                                            
attributable to                                                                              
transfers to    (69,236) 155,335 85,926   (20,526) 112,902 92,376   (7,581) (58,783) (66,364)
Return per      (0.53)p  1.19p   0.66p    (0.16)p  0.86p   0.70p    (0.06)p (0.45)p  (0.51)p 

General Notes to the Accounts

1.The financial information for the 6 month period ended 30 September 2009 is
unaudited and does not constitute statutory accounts within the meaning of the
Companies Act 2006. The financial information for the year ended 31 March 2009
has been extracted from the Company's statutory accounts for that period which
contained an unqualified report and which have been filed with the Registrar of
Companies. The accounting policies remain unchanged from those set out in the
Company's statutory accounts for the year ended 31 March 2009.

2.In accordance with PLUS Markets listing requirements Rule 9.12, the directors
take full responsibility for the figures and statements made in these accounts.

3. A provision of £35,000 has been made for corporation tax in respect of
capital gains made by the company. It is hoped that this will be more than
adequate, but brought forward losses are being investigated.

CHERWELL CAPITAL PLC Interim Unaudited Figures for 6 Months to 30.09.09


                           As at                   As at                  As at  
                         30.09.09                 31.03.09               30.09.08
                            GBP                     GBP                    GBP   
Fixed Assets                                                                     
Tangible Assets          -                        -                      2       
Investments              25,963                   433,963                262,278 
                         25,963                   433,963                262,280 
Current Assets                                                                   
Debtors                  126,068                  63,215                 66,882  
Cash at bank & in        443,354                  -                      -       
                         569,422                  63,215                 66,882  
Creditors                (48,221)                 (36,113)               (26,836)
Amounts falling due                                                              
within one year                                                                  
Net Current Assets       521,201                  27,102                 40,046  
Net Assets               547,164                  461,065                302,326 
Capital and Reserves                                                             
Called up share          326,633                  326,633                326,633 
Share premium            107,970                  107,970                107,970 
Other reserve            10,250                   10,250                 10,250  
Capital reserve -        404,751                  (46,543)               (46,543)
Capital reserve -        (154,839)                141,120                (30,567)
Revenue reserve          (147,601)                (78,365)               (65,418)
                         547,164                  461,065                302,326 
Net Asset Value per      4.2p                     3.5p                   2.3p    
2.5p share                                                                       

Note to the balance sheet as at 30.09.09

The listed investments have been revalued at the half year, if appropriate.
Unlisted equity investments are stated at cost or subsequent issue price in
accordance with the British Venture Capital Association guidelines for the
valuation of listed companies.


a d v e r t i s e m e n t